Implantable Neuromodulation System

About Cadence Neuroscience

Cadence Neuroscience is a private, clinical-stage medical device company pioneering a next-generation neuromodulation system for drug-resistant epilepsy. Incubated at Mayo Clinic and backed by venture capital, the company is developing a personalized therapy that aims to significantly increase the rate of seizure freedom compared to existing neurostimulation devices like VNS, RNS, and DBS. With a team of over 30 and strong clinical partnerships, Cadence is preparing for pivotal clinical studies to advance its lead program toward commercialization.

Therapeutic Areas

Other Drug-Resistant Epilepsy Drugs